Effect of Virtual Reality During Femoral Sheath Removal

June 11, 2026 updated by: İrem Canavar, Hasan Kalyoncu University

The Effect of Virtual Reality Glasses During Femoral Sheath Removal on Pain, Anxiety, and Vital Signs in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial

This randomized controlled study was conducted to evaluate the effect of virtual reality glasses used during femoral sheath removal on pain, anxiety, and vital signs in patients undergoing percutaneous coronary intervention. Patients were assigned to either a virtual reality intervention group or a control group receiving standard care. Pain, anxiety, and vital signs were assessed before, during, and after the procedure. The study aimed to determine whether virtual reality application could improve patient comfort and reduce procedure-related discomfort during femoral sheath removal.

Study Overview

Detailed Description

Percutaneous coronary intervention is a commonly used invasive procedure in the diagnosis and treatment of coronary artery disease. Femoral sheath removal performed after the procedure may cause pain, anxiety, and hemodynamic changes in patients. Non-pharmacological interventions are increasingly used to improve patient comfort and reduce procedure-related stress.

Virtual reality technology is considered an effective distraction method that may reduce pain perception and anxiety by directing patients' attention to immersive visual and auditory stimuli. Previous studies have demonstrated the positive effects of virtual reality applications during invasive and painful procedures.

This randomized controlled study aimed to investigate the effect of virtual reality glasses used during femoral sheath removal on pain, anxiety, and vital signs in patients undergoing percutaneous coronary intervention. Patients were randomly assigned to either the intervention group receiving virtual reality application during femoral sheath removal or the control group receiving standard care. Pain intensity, anxiety levels, and vital signs were evaluated before, during, and after the procedure.

The findings of this study may contribute to evidence-based nursing interventions aimed at improving patient comfort during femoral sheath removal procedures.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hatay
      • İskenderun, Hatay, Turkey (Türkiye)
        • İskenderun Devlet Hastanesi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients aged 18 years and older
  • Patients undergoing percutaneous coronary intervention via femoral access
  • Patients with only one femoral sheath catheter
  • Patients who did not receive analgesic medication before sheath removal
  • Patients without severe hemorrhage or major hematoma at the femoral sheath site
  • Patients able to communicate in Turkish
  • Patients without visual, hearing, or speech impairment
  • Patients without mental impairment affecting communication
  • Patients without psychiatric diagnosis and not using psychiatric medication

Exclusion Criteria:

  • Patients unwilling to participate or wishing to withdraw from the study at any stage

    • Patients who removed the virtual reality glasses during the intervention
    • Patients who experienced intolerance to virtual reality application (e.g., dizziness or nausea)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Reality Group
Participants received virtual reality glasses during femoral sheath removal
Virtual reality glasses were used during femoral sheath removal.
Other: Control Group
Participants received routine care during femoral sheath removal
Participants received routine care during femoral sheath removal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate
Time Frame: Periprocedural (5 minutes before sheath removal, 5 and 15 minutes after sheath removal)
Heart rate was measured in beats per minute using routine monitoring.
Periprocedural (5 minutes before sheath removal, 5 and 15 minutes after sheath removal)
Blood Pressure
Time Frame: Periprocedural (5 minutes before sheath removal, 5 and 15 minutes after sheath removal)
Systolic blood pressure and diastolic blood pressure were measured in mmHg using routine monitoring.
Periprocedural (5 minutes before sheath removal, 5 and 15 minutes after sheath removal)
Oxygen Saturation
Time Frame: Periprocedural (5 minutes before sheath removal, 5 and 15 minutes after sheath removal)
Oxygen saturation was measured as percent saturation using pulse oximetry.
Periprocedural (5 minutes before sheath removal, 5 and 15 minutes after sheath removal)
Body Temperature
Time Frame: 5 minutes before femoral sheath removal, 5 minutes after femoral sheath removal, and 15 minutes after femoral sheath removal
Body temperature was assessed using routine vital sign monitoring.
5 minutes before femoral sheath removal, 5 minutes after femoral sheath removal, and 15 minutes after femoral sheath removal
Pain Level
Time Frame: 5 minutes before femoral sheath removal, 5 minutes after femoral sheath removal, and 15 minutes after femoral sheath removal
Pain level was assessed using the Numeric Rating Scale (NRS). The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates severe pain. Higher scores indicate greater pain severity.
5 minutes before femoral sheath removal, 5 minutes after femoral sheath removal, and 15 minutes after femoral sheath removal
Anxiety Level
Time Frame: Before femoral sheath removal during completion of the participant information form, and 15 minutes after femoral sheath removal
Anxiety level was assessed using the State Anxiety Inventory (STAI). Higher scores indicate higher anxiety levels.
Before femoral sheath removal during completion of the participant information form, and 15 minutes after femoral sheath removal

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2025

Primary Completion (Actual)

January 5, 2026

Study Completion (Actual)

January 5, 2026

Study Registration Dates

First Submitted

May 8, 2026

First Submitted That Met QC Criteria

June 11, 2026

First Posted (Actual)

June 17, 2026

Study Record Updates

Last Update Posted (Actual)

June 17, 2026

Last Update Submitted That Met QC Criteria

June 11, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to privacy and confidentiality considerations

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Percutaneous Coronary Intervention

Clinical Trials on Virtual Reality

Subscribe